Larvol Delta - Noteworthy-Studies-to-Be-Presented-at-the-2026-Multidisciplinary-Head-and-Neck-Cancers-Symposium

ficerafusp alfa (BCA101) - Biocon

Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) - J&J

Keytruda (pembrolizumab) - Merck (MSD)

https://www.newswise.com/articles/noteworthy-studies-to-be-presented-at-the-2026-multidisciplinary-head-and-neck-cancers-symposium

Feb 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next